These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15419061)

  • 1. [Encephalitis due to arsenic treated with BAL].
    RODRIGUEZ PASCUAL C
    Actas Dermosifiliogr; 1950 Mar; 41(6):566-70. PubMed ID: 15419061
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of BAL on acute and chronic poisoning with arsenic and mercury].
    VOTAVA Z; VEJVODOVA L
    Cas Lek Cesk; 1950 May; 89(18):514-7. PubMed ID: 15420733
    [No Abstract]   [Full Text] [Related]  

  • 3. [BAL in the treatment of intoxication by arsenical and gold preparations].
    BERMUDEZ ABREU VP
    Rev Kuba Med Trop Parasitol; 1950; 6(3-4):59-65. PubMed ID: 15441436
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of BAL in the treatment of the injurious effects of arsenic, mercury and other metallic poisons.
    LONGCOPE WT; LUETSCHER JA
    Ann Intern Med; 1949 Oct; 31(4):545-54. PubMed ID: 15390530
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action of dimercapto-2-3-propanol in some arsenic poisonings].
    DELGA J
    Ann Pharm Fr; 1950 Feb; 8(2):106-10. PubMed ID: 15413841
    [No Abstract]   [Full Text] [Related]  

  • 6. [Two cases of severe arsenical erythroderma, successfully treated with the new BAL compound].
    NOGUER-MORE
    Actas Dermosifiliogr; 1948 Jan; 39(4):498-507. PubMed ID: 18865721
    [No Abstract]   [Full Text] [Related]  

  • 7. An adverse effect of BAL in a case of subacute arsenical polyneuritis, with observations on porphyrin metabolism.
    SANDS JH; BERRIS B; SCHERER LR
    N Engl J Med; 1950 Oct; 243(15):558-61. PubMed ID: 14780333
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical uses of 2,2-dimercaptopropanol (BAL); the systemic treatment of experimental arsenic poisoning (mapharsen, lewisite, phenyl arsenoxide) with BAL.
    EAGLE H; MAGNUSON HJ; FLEISCHMAN R
    J Clin Invest; 1946 Jul; 25(4):451-66. PubMed ID: 21001620
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urinary excretion of arsenic during poisoning by arsenic hydrogen and use of B.A.L].
    MOUREAU P
    Rev Med Liege; 1950 Jan; 5(2):36. PubMed ID: 15402551
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppression of treponemicidal action of arsenic with 2,3-dimercaptopropanol (BAL) report of clinical observations in five cases.
    De OREO GA
    Arch Derm Syphilol; 1947 Nov; 56(5):695-8. PubMed ID: 20272216
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of arsenical dermatitis with preparations of BAL.
    LONGCOPE WT; LUETSCHER JA
    J Clin Invest; 1946 Jul; 25(4):528-33. PubMed ID: 21001626
    [No Abstract]   [Full Text] [Related]  

  • 12. Arsenical encephalopathy treated with B. A. L.
    KONAR NR; DASS AK
    Calcutta Med J; 1950 Jun; 47(6):188-90. PubMed ID: 14772650
    [No Abstract]   [Full Text] [Related]  

  • 13. An explosive reaction following the simultaneous administration of sodium arsenite and dithioglycerol (BAL) in vivo.
    KOPPANYI T; SPERLING F
    Anat Rec; 1946 Dec; 96(4):501. PubMed ID: 20341381
    [No Abstract]   [Full Text] [Related]  

  • 14. BAL in the treatment of massive overdosage with mapharsen.
    ARMSTRONG CD; FLEMING WJ; THALMANN WG
    Calif Med; 1948 Oct; 69(4):247-52. PubMed ID: 18884800
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of 2,3-dimercaptopropanol (BAL) on the whole blood and plasma concentration of arsenic after mapharsen in cats.
    RIKER WF; ROSENFELD G
    J Pharmacol Exp Ther; 1946 Aug; 87(4 Suppl):72-5. PubMed ID: 20275115
    [No Abstract]   [Full Text] [Related]  

  • 16. The fate of arsenical vesicants in the skin and the effect of BAL (British anti-lewisite).
    Graham AF; Levvy GA; Chance AC
    Biochem J; 1947; 41(3):352-7. PubMed ID: 16748172
    [No Abstract]   [Full Text] [Related]  

  • 17. [Arsenical erythroma extinguished by B.A.L. and sodium thiosulfate].
    SMITH H
    Union Med Can; 1949 Dec; 78(12):1437. PubMed ID: 15394898
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of BAL in the treatment of arsenical neuropathy.
    MALHOTRA SL
    Ind Med Gaz; 1951 Aug; 86(8):340-3. PubMed ID: 14888288
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of industrial arsenical cancer occurring for the first time in Hungary and a comprehensive analysis of it.
    FRANK G
    Acta Derm Venereol; 1950; 30(2):163-72. PubMed ID: 15410558
    [No Abstract]   [Full Text] [Related]  

  • 20. The metabolism of arsenic in humans acutely intoxicated by As2O3. Its significance for the duration of BAL therapy.
    Mahieu P; Buchet JP; Roels HA; Lauwerys R
    Clin Toxicol; 1981 Sep; 18(9):1067-75. PubMed ID: 7318390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.